Hertfordshire and West Essex ICB
Prescribing, Policies and Pathways
Prescribing, Policies and Pathways
or
| Clinical area | Documents |
|---|---|
| Shared Care, Decision Making & Advice and Guidance | 57 |
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| A frequently asked questions document: Shared care for medicines and NHS shared care and specialist guided prescribing service specification. | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
| Amiodarone Shared Care Protcol | Arrythmia | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol | Amber protocol | Shared care protocol | West Essex |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol children and young people (methylphenidate, lisdexamfetamine, dexamfetamine, atomoxetine or guanfacine) | Amber protocol | Shared care protocol | West Essex |
| Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol - children, young people and adults | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
| Cannabidiol (Epidiyolex®) | Tertiary care indication (NHSE) Suitable for shared care between tertiary and secondary care providers. Adjunctive treatment with clobazam for treating seizures associated with Dravet syndrome and Lennox-Gastaut syndrome (LGS) | Red | Decision document | Hertfordshire and West Essex ICB |
| Shared care | Attention deficit hyperactivity disorder (ADHD) by Private Provider | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Shared Care | Shared Care Principles | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Shared care | Initiation by a Private Provider | Amber protocol | Patient information | Hertfordshire and West Essex ICB |
| Acetylcholinesterase (AChE) inhibitor | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Apomorphine | Parkinson's disease | Red | Decision document | Hertfordshire and West Essex ICB |
| Asthma | Inhaled corticosteroids (ICS) choices | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Bariatric Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Cannabis-based medicinal preparations | Intractable nausea & vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy | Red | Position statement | Hertfordshire and West Essex ICB |
| Cenobamate | Focal onset seizures | n/a | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Clonidine | Attention deficit hyperactivity disorder (ADHD) | Red | Decision document | Hertfordshire and West Essex ICB |
| Delta-9-tetrahydrocannabinol [THC] and cannabidiol [CBD] spray (Sativex®) | Spasticity in multiple sclerosis (MS) | Red | Decision document | Hertfordshire and West Essex ICB |
| Donepezil | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Dual GIP with GLP-1 RA or GLP-1 RA with Insulin guidance document | Type 2 Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
| Fludrocortisone | Orthostatic Hypotension | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Galantamine | Alzheimer's disease dementia | Amber initiation | Decision document | East and North Hertfordshire, South and West Hertfordshire |
| Gender Dysphoria | n/a | n/a | Hertfordshire and West Essex ICB | |
| How to guide: Searching HWE prescribing guidance website | n/a | n/a | Hertfordshire and West Essex ICB | |
| Hysterectomy in Gender Dysphoria | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Inspection - CQC | Managing Medicines in a GP Practice | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Liothyronine - Position Statement | Hypothyroidism | Amber protocol | Position statement | Hertfordshire and West Essex ICB |
| Liothyronine Review Algorithm | Hypothyroidism | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Lithium Primary Care action plan | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Low molecular weight heparin (LMWH) | Anticoagulation | Red | Decision document | Hertfordshire and West Essex ICB |
| Melatonin | Insomnia - Neurodevelopmental Disorders in patients under the age of 18 years | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Memantine | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Midodrine | Orthostatic Hypotension | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Nabilone | Intractable chemotherapy induced nausea and vomiting | Red | Decision document | Hertfordshire and West Essex ICB |
| Palliative care formulary | Palliative care | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Penicillamine | Rheumatoid Arthiritis | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Penicillamine | Tertiary care indication (NHSE) | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Prescription | Private consultation | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Prescription - repeat | Prescriber guide with tips | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Rifaximin | Hepatic encephalopathy | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
| Rivastigmine | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
| Sacubitril valsartan | Heart failure | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Sativex® and other licensed cannabis -based medicinal products | Red | Decision document | Hertfordshire and West Essex ICB | |
| Sirolimus oral | Transplant rejection (prescribe by brand) NHSE for existing patients | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| Tacrolimus oral | Transplant rejection (prescribe by brand) NHSE for existing patients | Amber protocol | n/a | Hertfordshire and West Essex ICB |
| User guide for eRD (EMIS and SI) | eRDs | n/a | Prescribing support document | Hertfordshire and West Essex ICB |